| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |